Cargando…

ODP644 Oral Dosing of Progestogenic Androgens for Male Contraception Show Low Serum Testosterone and High Acceptability in Placebo-Controlled Trials

A promising development in hormonal male contraception (HMC) is a class of bifunctional prodrugs that combine both androgenic and progestogenic activities into a single molecule. Examples of these prodrugs currently being studied are dimethandrolone undecanoate (DMAU) and 11β-methyl-19-nortestostero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobsohn, Tamar, Nguyen, Brian, Fernando, Frances, Brown, Jill, Blithe, Diana, Lee, Min, Yuen, Fiona, Swerdloff, Ronald, Liu, Peter, Wang, Christina, Farrant, Maritza, Anawalt, Bradley, Thirumalai, Arthi, Bremner, William, Page, Stephanie, Amory, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625429/ http://dx.doi.org/10.1210/jendso/bvac150.1398

Ejemplares similares

SUN-LB042 The Novel Androgen 11β-Methyl-19-Nortestosterone Dodecylcarbonate (11β-MNTDC) Effectively Suppresses Gonadotropins and Testosterone in Healthy Men: A Potential Oral Male Hormonal Contraceptive
por: Yuen, Fiona, et al.
Publicado: (2019)

FRI436 Design Of An International Male Contraceptive Efficacy Trial Using A Self-administered Daily Topical Gel Containing Testosterone And Nestorone™
por: Page, Stephanie T, et al.
Publicado: (2023)

SAT-LB7 Acceptability of Oral 11β-Methyl-19-Nortestosterone Dodecylcarbonate (11β-MNTDC) as a Potential Hormonal Male Contraceptive Pill: Results From a Randomized, Placebo-Controlled Trial
por: Nguyen, Brian T, et al.
Publicado: (2020)

SAT-040 Changes in Metabolic Parameters After Administration of Novel Oral Androgens with Progestational Activity for 28 Days
por: Yuen, Fiona, et al.
Publicado: (2020)

SAT-044 Treatment of Hypogonadal Men with a New Oral Testosterone Undecanoate (TU) Formulation Improves Psychosexual, Well-Being and Body Composition and Bone Density Parameters
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

ODP404 Effects of Empagliflozin on Serum Androgens Levels in Men Without Diabetes
por: Kosinski, Christophe, et al.
Publicado: (2022)

Optimal dose of PG600 when given to progestogen-synchronized ewes during anestrus as affected by day of the year and temperature()
por: Cross, Lucy J, et al.
Publicado: (2018)

SUN-227 Monitoring Testosterone (T) Levels in Men Receiving Oral Testosterone Undecanoate (TU): Challenges Due to Post-Collection Conversion of TU-to-T and a Path Forward
por: Swerdloff, Ronald, et al.
Publicado: (2019)

ODP609 Optimizing Sexual Function and Libido in Men with Androgen Deficiency due to Hypogonadotropic Hypogonadism
por: Comite, Florence, et al.
Publicado: (2022)

Male Contraception
por: Abbe, Carmen R., et al.
Publicado: (2020)

PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)
por: Swerdloff, Ronald, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

THU644 Gene-by-PCOS Interactions In Cardio-metabolic Traits On A Panel Of Genetically Diverse Strains Of Mice
por: Velez, Leandro Martin, et al.
Publicado: (2023)

ODP537 A 1.6cm Androgen Secreting Ovarian Leydig Cell Tumor Evades Detection on Multiple Imaging Modalities
por: DeLorenzo, Frank, et al.
Publicado: (2022)

SAT-219 A Novel 1-Year Contraceptive Vaginal System Delivering Segesterone Acetate and Ethinyl Estradiol: Effects on Lipids and other Hepatic Proteins
por: Archer, David, et al.
Publicado: (2019)

ODP630 Antibiotics Transiently Reduce Circulating Cortisol and Inflammatory Biomarker Levels in Healthy Sprague Dawley Rats
por: Barlow, Gillian, et al.
Publicado: (2022)

ODP423 Postmenopausal Virilization Secondary to A Rare Left Ovarian Androgen-Secreting Leydig Cell Tumor Localized Using Ovarian Vein Sampling
por: Shuster, Shirley, et al.
Publicado: (2022)

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

Progestogen-only oral contraceptives: Number 4 - April 2022
por: Machado, Rogério Bonassi, et al.
Publicado: (2022)

ODP600 Is this a case of surreptitious hormonal supplements?
por: Rimal, Priya, et al.
Publicado: (2022)

OR25-04 Factors Affecting Testosterone Concentrations In Men: Individual Participant Data Meta-analyses From The Androgens In Men Study
por: Marriott, Ross J, et al.
Publicado: (2023)

ODP403 Diversity of Estrogen-Responsive Genes in Endometriotic Lesions
por: Izawa, Masao, et al.
Publicado: (2022)

ODP422 PCOS is Associated with Increased Incidence of Co-morbidities
por: Vine, Donna, et al.
Publicado: (2022)

ODP428 The Effects of Asprosin Pubertal Maturation in Female Rats
por: OZ, Zeynep Dila, et al.
Publicado: (2022)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

Hormonal Male Contraception: Getting to Market
por: Page, Stephanie T., et al.
Publicado: (2022)

Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
por: Kulier, Regina, et al.
Publicado: (2004)

The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

ODP431 Adiposity in menstrual dysfunction and the role of laboratory testing in diagnosis
por: Fazeli, Pouneh, et al.
Publicado: (2022)

ODP410 Exposure to Transgender Teaching in Internal Medicine Residents and Established Providers
por: Malek, Rana, et al.
Publicado: (2022)

ODP424 Postprandial Adipose Insulin Resistance in Adolescent Girls with PCOS and Obesity
por: Finn, Erin, et al.
Publicado: (2022)

OR35-05 Interaction of Cortisol with Testosterone Predicts Abdominal Fat Mass in Normal-weight Polycystic Ovary Syndrome Women with Normal Serum 11-Oxygenated Androgens
por: Anthony Dumesic, Daniel, et al.
Publicado: (2023)

Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022)

ODP427 The Concomitant Existence of Turner Syndrome and Non-classic Congenital Adrenal Hyperplasia
por: Go, Hanah, et al.
Publicado: (2022)

ODP405 Effects of Gonadotrope-Specific Knockout of Creb on HPG Axis Function in Mice
por: Hausken, Krist, et al.
Publicado: (2022)

ODP430 Unusual Complication after a controlled ovarian stimulation presenting as ascites
por: Ortiz, Yineli, et al.
Publicado: (2022)

SUN-LB039 Novel Use of Thromboelastography (TEG) to Investigate the Prothrombotic Effects of Testosterone Replacement Therapy (TRT) for Androgen Deficiency (AD) Established with Diagnostic Rigor (DR)
por: Subramaniam, Shreya, et al.
Publicado: (2019)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_91afg44l5q6gq54ncq3aeedllt